title: Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
abstract: Two major genes determining predisposition to breast cancer, termed BRCA1 and BRCA2, have been mapped to the long arms of chromosomes 17 and 13, respectively. Each locus is believed to account for approximately 40% of cases of familial breast cancer. We used linkage and haplotype analysis with simple tandem repeat polymorphisms at chromosomal bands 17q21 and 13q12 to determine the contribution of the BRCA1 and BRCA2 genes to predisposition to breast cancer in four Australian breast cancer kindreds, one of which had two male cousins with breast cancer. Surprisingly all families segregated a haplotype of markers on 13q and showed positive lod scores supporting linkage to BRCA2. In addition, haplotype analysis identified an informative recombination between D13S260 and D13S171 in one affected individual, which refines the localisation of BRCA2 to between D13S260 and D13S267; a distance of 2-3 cM. Tumours of the stomach and cervix, as well as melanoma and leukaemia/lymphoma also occur in these pedigrees but the numbers are too low to determine whether they may be significantly associated with BRCA2 carrier status. Our results confirm the existence of BRCA2 on the long arm of chromosome 13 and support previous findings that this locus is likely to confer risk in families with affected males. Furthermore, our observations suggest that the BRCA2 gene may also contribute to the development of other neoplasma.
authors.affiliation: Human Genetics Laboratory, Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, Herston, Australia.
authors.forename: S M
authors.initials: SM
authors.lastname: Grimmond
authors.forename: J M
authors.initials: JM
authors.lastname: Palmer
authors.forename: M K
authors.initials: MK
authors.lastname: Walters
authors.forename: C
authors.initials: C
authors.lastname: Scott
authors.forename: D J
authors.initials: DJ
authors.lastname: Nancarrow
authors.forename: B T
authors.initials: BT
authors.lastname: Teh
authors.forename: C
authors.initials: C
authors.lastname: Elmes
authors.forename: C
authors.initials: C
authors.lastname: Pyke
authors.forename: S K
authors.initials: SK
authors.lastname: Khoo
authors.forename: I
authors.initials: I
authors.lastname: Bennett
authors.forename: N
authors.initials: N
authors.lastname: Wetzig
authors.forename: N K
authors.initials: NK
authors.lastname: Hayward
mesh_terms: D001315:Australia; D019313:BRCA1 Protein; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000235:genetics*; D018567:Breast Neoplasms, Male / Q000235:genetics; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D005260:Female; D008040:Genetic Linkage / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics; D010375:Pedigree; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics; D012091:Repetitive Sequences, Nucleic Acid; D012307:Risk Factors; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D019313:BRCA1 Protein; D024682:BRCA2 Protein; D005819:Genetic Markers; D009363:Neoplasm Proteins; D014157:Transcription Factors